abstract |
A compound for the manufacturing of a medicament for reducing or preventing mesothelial cell damage is described. The compound comprises a mixture of a carrier gas and between 1 volume percent and 29 volume percent of nitrous oxide gas (N 2 O) and can be used for prevention of adhesion formation, pain reduction, reducing or preventing acute inflammation, reducing or preventing CO 2 resorbtion or reducing tumor cell implantation upon surgery. The compound may comprise for example between 1 and 29 volume percentage nitrous oxide gas, preferably between 5 and 20 volume percentage nitrous oxide gas, more preferably between 5 and 10 volume percentage nitrous oxide gas. The invention also relates to such a compound for the manufacturing of a medicament for preventing adhesion formation, to the use of such a compound in surgery for preventing adhesion formation, to a system and controller for supplying or using such a compound and to a corresponding method. |